Ronald Oudiz
Chief · University of Southern California/Los Angeles General Medical Center
Credentials: · · · ·
History
Research
American Journal of Respiratory and Critical Care Medicine · 2002 · 1,065 citations
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
New England Journal of Medicine · 2015 · 918 citations
Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology
Review · Journal of the American College of Cardiology · 2013 · 822 citations
- VM
24 papers
- AF
19 papers
17 papers
- RB
17 papers
15 papers
- LR
14 papers
- HG
13 papers · 6 as a resident
- SS
13 papers
Grants
- 2005–2010
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $27.6K · Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
- 2003–2009
Cardiopulmonary Exercise Testing: Pulmonary Hypertension
National Center for Research Resources · K23
Contact PI · $670.3K · Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
Clinical trials
- 2013–2019
Principal investigator · Completed · Phase 2
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- 2010–2016
Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication
Principal investigator · Completed · Phase 4
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- 2024
Assessing the Utility of Submaximal CPET in Treatment Management of PAH
Site PI · Unknown
Shape Medical Systems, Inc.